Matinas BioPharma Holdings Inc

The current institutional shareholding score of Matinas BioPharma Holdings Inc is 3.00, ranking 192 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 7.98%, representing a quarter-over-quarter increase of 49.61%. The largest institutional shareholder is James Simons, holding a total of 19.56K shares, representing 0.45% of shares outstanding, with 0.90% increase in holdings.